75834-195-25 |
75834-195 |
HUMAN PRESCRIPTION DRUG |
GLYCOPYRROLATE |
glycopyrrolate |
INJECTION |
INTRAMUSCULAR; INTRAVENOUS |
20211025 |
N/A |
ANDA |
ANDA212591 |
Nivagen Pharmaceuticals, Inc. |
GLYCOPYRROLATE |
.2 mg/mL |
25 VIAL, MULTI-DOSE in 1 CARTON (75834-195-25) / 5 mL in 1 VIAL, MULTI-DOSE |
75834-196-10 |
75834-196 |
HUMAN PRESCRIPTION DRUG |
GLYCOPYRROLATE |
glycopyrrolate |
INJECTION |
INTRAMUSCULAR; INTRAVENOUS |
20211025 |
N/A |
ANDA |
ANDA212591 |
Nivagen Pharmaceuticals, Inc. |
GLYCOPYRROLATE |
.2 mg/mL |
10 VIAL, MULTI-DOSE in 1 CARTON (75834-196-10) / 20 mL in 1 VIAL, MULTI-DOSE |
75834-194-25 |
75834-194 |
HUMAN PRESCRIPTION DRUG |
GLYCOPYRROLATE |
glycopyrrolate |
INJECTION |
INTRAMUSCULAR; INTRAVENOUS |
20211025 |
N/A |
ANDA |
ANDA212591 |
Nivagen Pharmaceuticals, Inc. |
GLYCOPYRROLATE |
.2 mg/mL |
25 VIAL, SINGLE-DOSE in 1 CARTON (75834-194-25) / 2 mL in 1 VIAL, SINGLE-DOSE |
75834-193-25 |
75834-193 |
HUMAN PRESCRIPTION DRUG |
GLYCOPYRROLATE |
glycopyrrolate |
INJECTION |
INTRAMUSCULAR; INTRAVENOUS |
20211025 |
N/A |
ANDA |
ANDA212591 |
Nivagen Pharmaceuticals, Inc. |
GLYCOPYRROLATE |
.2 mg/mL |
25 VIAL, SINGLE-DOSE in 1 CARTON (75834-193-25) / 1 mL in 1 VIAL, SINGLE-DOSE |